MedPath
NMPA Approval

Rifamycin Sodium Injection

国药准字H20068150

April 20, 2021

国药准字H20068150

Drug Information

利福霉素钠注射液

注射剂

5ml:0.25g(25万单位)

化学药品

April 20, 2021

Company Information

Applicant Company

鹿邑县产业集聚区、同源路1号

Manufacturing Company

河南省鹿邑县玄武经济开发区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

利福霉素钠注射液 - NMPA 批准文号 | MedPath